EPAS1 and breast carcinoma: HIF1A transforms normal stem cells into cancer stem cells by altering the niche components and functions of stem cells, leading to an increase in drug-resistant cancer stem cells in solid tumors [150], and HIF1A- and HIF2A-dependent AlkB homolog 5 expression induces the breast cancer stem cell phenotype [151].